人脑胶质瘤中全长新基因PPIL3的生物信息学研究  

Bioinformatics of one novel full-length gene related to human glioma

作　　者：祁震宇[1] 王中[1] 李瑶[2] 顾少华[2] 谢毅[2] 

机构地区：[1]苏州大学附属第一医院神经外科,215006 [2]上海复旦大学遗传工程国家重点开放实验室

出　　处：《中华实验外科杂志》2011年第6期947-950,共4页Chinese Journal of Experimental Surgery

基　　金：基金项目：苏州市社会发展及医药计划资助项目（SS08046）

摘　　要：目的应用基因芯片技术获取正常成人脑组织与人脑胶质瘤中差异表达的基因，并对其中1条基因进行初步研究。方法抽提正常成人脑组织与人脑胶质瘤组织中的mRNA制备探针，经杂交、洗涤后，通过计算机观察两者表达谱的差异，对681F05克隆子进行Northernblot和生物信息学分析。结果通过4次基因芯片筛选，获得15条与胶质瘤相关的新基因，经Northernblot证实681F05基因在人正常脑组织中低表达，而在人脑胶质瘤中高表达。BLASTn和BLASTx分析显示，它们编码蛋白与线虫Cyp-10蛋白同源性分别为52％和72％。cDNA序列分析发现此两个克隆是同一个基因[命名为cyclophilin．1ikegene（PPIL3）]的两个不同的剪切体（PPIL3a和PPIL3b）。结论基因芯片筛选正常脑组织与人脑胶质瘤差异表达的基因具有样品用量少、高质量、高速度、高敏感等特性。681F05基因可能是与人脑胶质瘤形成有关的一条全长新基因。Objective To obtain differentially expressed genes related to human glioma using eDNA microarray and study the characterization of one novel full-length gene. Methods Total RNA was extracted from human glioma tissues and normal brain tissues, and mRNA was used to make probes. After hybridization and washing procedure, the results of hybridization were scanned using computer system. One gene named 681F05 clone was subsequently analyzed by northern blotting and bioinformatic analysis. Re- suits We obtained 15 differentially expressed genes to human glioma through 4 times hybridizations and scanning. Northern blotting analysis confirmed 681F05 clone was down-regulated in human brain tissue and up-regulated in human glioma tissues. The analysis of BLASTn and BLASTx showed that clone 681F05 iso- lated was two cDNA clones encoding two novel proteins which showed 52% and 72% identity to the cyclophilin isoform 10 of C. Elgans, respectively. Sequence analysis revealed these two cDNA clones were two different splicing variants of a novel cycophilin-like gene （PPIL3a and PPIL3b）. Conclusion cDNA microarray technology can be successfully applied to identify differentially expressed genes. The novel fulllength gene of human PPll3 may be correlated with tumorigenesis of human glioma.

关 键 词：基因芯片 脑胶质瘤 差异表达 

分 类 号：R739.41[医药卫生—肿瘤]